International
The Morning Science

What science found today

‹
 

Research

Commonly mutated gene could be a therapeutic target in sarcoma

Medical Xpress ·

Commonly mutated gene could be a therapeutic target in sarcoma

The Brief

  • Researchers at MD Anderson Cancer Center report that sarcomas lacking the ATRX gene tend to be more aggressive.
  • Such sarcomas may be particularly vulnerable to TEAD inhibitors, a class of targeted therapies.

Why it matters

ATRX loss may help identify sarcoma patients who could respond to TEAD inhibitors, pointing to a possible targeted treatment approach for a commonly mutated gene.

Who’s affected

  • oncologists and sarcoma researchers
  • patients with ATRX-deficient sarcomas

Researchers at The University of Texas MD Anderson Cancer Center have discovered that sarcomas lacking the ATRX gene tend to be more aggressive and may be particularly vulnerable to a class of targeted therapies known as TEAD inhibitors. The findings identify ATRX loss as both a…

How do you feel about this?

0 Comments

    Commonly mutated gene could be a therapeutic target in sarcoma – The Morning Science